A limited number of reports of estrogen levels in prepubertal and early pubertal boys have been published because previous estrogen assays have lacked adequate sensitivity to quantitate circulating estrogen concentrations. Development of a new ultrasensitive assay has permitted measurement of estrogen levels in 23 normally growing boys progressing through puberty. Concentrations were measured at approximately 4-month intervals over a 5-to 8-yr period. The levels increased with maturation in all and correlated directly with chronological age, bone age, weight, height, pubertal stage, and testosterone and insulin-like growth factor-I levels. Of these factors, the level of testosterone had the greatest influence on the estrogen concentration. The time from peak growth velocity also significantly correlated with estrogen level. The estrogen level correlated positively with growth velocity before the time of peak growth velocity and negatively after peak growth velocity. The estrogen levels first increased significantly an average of 3 yr after pubertal onset and reached a peak by 5 yr after pubertal onset. Peak growth velocity was attained an average of 3 yr after pubertal onset. The greatest increase in the rate of rise of the estrogen level was an 11-fold rise during the year in which puberty began. The next most significant increase was a 4.8-fold rise 3 yr after pubertal onset. With respect to pubertal stage, the greatest absolute change occurred from stage 4 to stage 5 and the greatest fold change occurred from stage 1 to stage 2. The estrogen level did not significantly correlate with the 24-h GH level.
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In conclusion, circulating estrogen levels are very low in all boys prepubertally and rise steadily during adolescent development. The estrogen level is closely related to testosterone concentration and to the time of peak growth velocity. These findings are consistent with the hypothesis that estrogen at low levels augments skeletal growth and maturation in boys (as well as girls). They are also consistent with the hypothesis that continued exposure to estrogen leads to epiphyseal fusion. Further studies are required to define the separate and combined roles of estrogen, GH, and testosterone, as well as other factors, on growth and sexual development at puberty. (J Clin Endocrinol Metub 81: 3203-3207, 1996) C IRCULATING estrogen levels have not been previously reported in boys because of the lack of adequate sensitivity of available assays. Previous studies have reported estrogen levels in older prepubertal children of approximately 29.4 pmol/ L (8 pg / mL) (l-4). These levels were close to the detection limit of the assay; therefore, they may not be completely reliable. A recent report of estrogen levels in prepubertal girls and boys utilized a new recombinant cell bioassay for estrogen and reported levels of 2.2 pmol/ L (0.6 pg/mL) in girls and 0.29 pmol/L (0.08 pg/mL) in boys (5). These data are consistent with the hypothesis that estrogen may exert important biological effects at concentrations well below the minimal detectable concentration in conventional RIAs.
The GH-insulin-like growth factor-I (IGF-I) axis is only one component in the regulation of the pubertal growth spurt. Estrogen may play an important role in the growth spurt in boys as well as girls. The infusion of estradiol at the dose of 4 pg/day triples the ulnar growth rate in boys (6). The plasma estradiol level corresponding to this dose may be approximately 15 pmol/ L (4 pg / mL) based on extrapolation from the levels attained at significantly higher dose infusions. Additionally, ethinyl estradiol doses as low as 25-100 ngf kg per day are associated with increased growth velocity in girls with Turner's syndrome (7-9), and doses as low as 100 ng / kg per day are associated with increased GH release in girls with Turner's syndrome (10). To determine the estrogen levels and the relationships among estrogen level, growth, and GH levels in boys, we used the recently described recombinant cell bioassay to measure estrogen levels in 23 normally growing boys progressing into and through puberty.
Subjects and Methods
Study subjects The increased sensitivity of the assay comes at least in part from the overexpression of estrogen receptor in the system, the high amplitude response produced by the tandem arrangement of the two estrogen response elements, and the low background in the absence of estrogen. The assay was highly specific for estradiol.
The intraassay coefficient of variation (CV) at 7.4 pmol/L (2 pg/mL) was 15%. The interassay CV at 7.4 pmol/L was 13%.
GH assay
Serum GH concentrations were determined using Nichols Institute (San Juan Capistrano, CA) immunoradiometric assay kits with horse serum matrix. All samples from any one study period were analyzed in the same assay run, with samples from as many study days as possible for any one child assayed on the same day. Intra-and interassay CVs were less than 8% and lo%, respectively.
The lower limit of assay sensitivity was determined to be 0.5 pg/L, and all samples with GH concentrations less than this were set equal to 0.5 kg/L for analysis.
Testosterone assay
Serum testosterone levels were determined using a commercial solidphase RIA (Coat-A-Count, Diagnostic Products Corporation, Los Angeles, CA). The minimal detectable dose was 0.70 nmol/L
IGF-I assay
Plasma IGF-I levels were assayed following acid-ethanol extraction in kits from the Nichols Institute using a double antibody RIA. The intraand interassay CVs were less than 5.2% and 11.2%, respectively, with a lower limit of sensitivity of 34 ng/mL. 
Estrogen Results
The estrogen level increased with advancing pubertal stage in all boys (Table 1 and Fig. 1) . The increase across all stages was significant, but the only significant increase between individual stages was between stages 4 and 5. The greatest absolute increase in estrogen level relative to pubertal stage was between stages 4 and 5. The greatest rate of increase was an 11-fold rise between stages 1 and 2.
The estrogen level also increased significantly with increasing chronological age (data not shown), increasing bone age (Fig. 2) , increasing time relative to pubertal onset (Fig. 3) , and increasing time relative to peak growth velocity (Fig. 3) . Changes from year to year relative to chronological age were not statistically significant. Changes year to year relative to bone age only became significant from bone age 13-14 yr.
The first significant change in the estrogen level occurred during the year immediately preceding peak growth velocity (Fig. 3A) , which was approximately 3 yr after pubertal onset (Fig. 3B) . The estrogen level also increased significantly during the year following that of peak growth velocity. The greatest absolute changes in the estrogen level also occurred during the year following attainment of peak growth velocity, and 5 yr after pubertal onset. The greatest fold changes in estrogen occurred during the year immediately preceding peak growth velocity, a 4-fold rise, and during the year immediately preceding pubertal onset, an 11-fold rise.
The estrogen level correlated significantly with bone age, weight, height, testosterone, IGF-I, time from pubertal onset, and time from peak growth velocity (Figs. 4 and 5) . The strongest univariate correlation was with testosterone level. Testosterone also had the most influence on the estrogen level as determined by multivariate analysis including pubertal stage, peak growth velocity, time of pubertal onset, body mass index (defined as weight in kilograms divided by the square of the height in meters), GH, IGF-I, and chronological age (data not shown).
The estrogen level and mean 24-h GH level did not significantly correlate.
GH
Mean 24-h GH level increased slightly to a peak at stage 4 of puberty coincident with the peak growth velocity (Table  1 and Fig. 1 ). Mean 24-hour GH level first increased significantly between -2 and -1 yr before peak growth velocity (Fig. 3A) and 2 yr after pubertal onset (Fig. 3B) . Mean GH level also increased significantly between -1 and 0 yr before peak growth velocity but decreased significantly between 0 and 1 yr after peak growth velocity. It continued to decrease each subsequent year, although this downward trend did not reach statistical significance. Peak GH level occurred during the year of peak growth velocity and 2 and 3 yr after pubertal onset.
Testosterone
The testosterone level first increased significantly between -2 and -1 yr before peak growth velocity (Fig. 3A) and 2 yr after pubertal onset (Fig. 38) . The testosterone level also increased significantly between -1 and 0 yr before peak growth velocity, between 0 and 1 yr after peak growth velocity, and 3 and 4 yr after pubertal onset.
Multivariate analysis
Of all the parameters considered, the testosterone concentration and the mean GH level had the greatest influence on peak growth velocity and on pubertal onset using multivar- JCE C M . 1996 Volt31 . iate analysis; however, there was an additional component influencing the timing of peak growth velocity accounted for only by the estrogen concentration ( Table 2 ). The time relative to peak growth velocity was a better predictor of the estrogen level than was the time relative to pubertal onset using multivariate analysis (Table 2) .
Discussion
Most previous studies of circulating estrogen levels in boys have been limited by the sensitivity of available assays (l-4). We describe estrogen levels as normally growing boys progress into and through puberty, using a recently described recombinant cell bioassay. The first significant rise in the estrogen level occurred simultaneously with the peak growth velocity, an average of 3 yr after pubertal onset. This relationship between peak growth velocity and the rise in estrogen level further supports the hypothesis that estrogen at low levels may be a mediator of skeletal growth and maturation in boys as well as girls. The estrogen levels continued to increase and remained at the relatively higher levels toward the end of puberty, although growth velocity decreased as epiphyseal closure became imminent. This pattern is consistent with the hypothesis of a biphasic effect of estrogen on growth velocity, in which low levels accelerate growth in concert with increasing testosterone and GH lev- a Where F ratio is the statistic testing the effect is 0, and P is the probability that the effect is random error.
els, and high levels accelerate epiphyseal fusion, although these hypotheses were not directly tested in this study. It is also consistent with the hypothesis that sustained levels of estrogen over time lead to epiphyseal fusion, and with the recent description of a man with estrogen resistance because of a mutant estrogen receptor, who had tall stature and incompletely fused epiphyses late in his third decade (12). Testosterone levels rose during puberty in all boys. The first significant rise occurred 1 yr before peak growth velocity. Thus, the initial significant changes in estrogen level lagged the changes in testosterone by 1 yr.
The highest mean GH levels occurred simultaneously with the peak growth velocity as previously described (13), although this is the first longitudinal confirmation of the previous cross-sectional observations. This suggests a relationship between GH and sex steroid secretion, and also suggests that GH is one of the major mediators of the pubertal growth spurt. Similar to the testosterone level, the first significant rise in mean GH level occurred in the year prior to peak growth velocity. Direct effects of androgens and estrogen on growth as well as indirect effects of estrogen on growth mediated by augmented secretion of GH have been described (14). Androgens do not appear to play as much a role in bone age maturation and the pubertal growth spurt as do estrogens as described in boys treated with oxandrolone (15), in the description of a genetic female with pseudohermaphroditism caused by an aromatase-gene defect in whom bone age was delayed and there was no pubertal growth spurt (16), and in boys with familial male precocious puberty, who may require treatment with aromatase inhibitors as well as antiandrogens to slow skeletal growth and bone maturation (17). Estrogen is also involved in the cessation of growth, or epiphyseal fusion, in boys and girls. The estrogen levels described in this study are consistent with direct and indirect roles for estro- gen, as well as a role in epiphyseal closure. Patients with complete androgen insensitivity have a pubertal growth spurt that is normal for a genetic female (18). We conclude that estrogen levels are very low in all boys prepubertally, begin to increase even before the external signs of puberty are obvious, and then rise steadily during the remainder of adolescent development. The circulating estrogen level is closely related to testosterone concentration and to the time of peak growth velocity. These findings are consistent with the hypothesis that estrogen at low levels influences skeletal growth and maturation in boys (as well as girls). These findings are also consistent with the hypothesis that continued exposure to estrogen accelerates epiphyseal fusion. Further studies are required to define the hormonal mechanisms of estrogen action at puberty.
